The designed ultrasmall silica nanoparticles, which were functionalized with anti-human epidermal growth factor receptor 2 (HER2) single-chain variable fragments, exhibited high tumor-targeting efficiency and efficient renal clearance [87]. This evidence concerns the gene ERBB2 and neoplasm.